NEAA drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| NPCs | interacts_with | NEAA | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations. (2017)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| neaa | drug | 5 | 9 |
| non-essential amino acid | drug | — | — |
| non‑essential amino acids | drug | — | — |